Costs and cost-effectiveness of hiv early infant diagnosis in low- and middle-income countries: a scoping review

HIGHLIGHTS

• who: Kira Elsbernd from the Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany have published the article: Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review, in the Journal: (JOURNAL)
• what: Cost-effectiveness analyses in this scoping review most commonly compared costs and health benefits of an intervention with current best practice or standard-of-care.
• how: The authors identified 1786 studies including 1011 studies from database searches and 775 studies from the references of reviews. All . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.